Skip to content

Bruker 公司

US · BRKR #1504 按市值排名 上市于 1970
54.80 -1.74 -3.08%
实时 - 追踪5344个代码 - 心跳于481秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
95.20% -0.01pp
机构数量
494 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund77.71%
Individual/Insider31.89%
Hedge Fund11.05%
Public Company2.67%
Government Pension Fund2.45%
Private Company0.87%
Sovereign Wealth Fund0.24%

主要股东 截至 2026-08-15

Frank Laukien 26.53% · 40.42M 股
Orbis Investment Management Limited 11.77% · 17.94M 股
FMR 9.80% · 14.93M 股
BlackRock 7.49% · 11.41M 股
Pallas Capital Advisors LLC 6.22% · 9.48M 股
Joerg Laukien 4.93% · 7.52M 股
Vanguard Capital Management, LLC 3.65% · 5.56M 股
Strategic Advisers LLC 3.48% · 5.31M 股
Vanguard Portfolio Management, LLC 3.21% · 4.89M 股
Sculptor Capital Management, Inc. 3.04% · 4.63M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 26次买入 · 23次卖出

姓名职务持股比例
Frank Laukien Chairperson & CEO 26.53%
Joerg Laukien Former Director 4.93%
Juergen Srega President of Bruker CALID Group & Bruker Daltonics Division 0.10%
Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate 0.06%
Richard Packer Independent Director 0.06%
Gerald Herman Chief Financial Officer 0.04%
William Linton Lead Independent Director 0.04%
John Ornell Independent Director 0.02%
Robert Rosenthal Independent Director 0.02%
Falko Busse President of Bruker BioSpin Group 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-14 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Derivative Exercise and Sale -2,000 $22.19–52.87
2026-08-16 Wolfgang Pusch -- Open Market Disposition -3,473 $56.90
2026-08-14 Frank Laukien Chairperson & CEO Sale to Issuer -4,760 $57.70
2026-08-14 Frank Laukien Chairperson & CEO Other Acquisition +29,463 --
2026-08-14 Frank Laukien Chairperson & CEO Other Derivative Acquisition +71,651 $63.47
2026-08-14 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Sale to Issuer -2,984 $57.70
2026-08-14 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Other Acquisition +14,443 --
2026-08-14 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Other Derivative Acquisition +11,708 $57.70
2026-08-14 Gerald Herman Chief Financial Officer Sale to Issuer -2,724 $57.70
2026-08-14 Gerald Herman Chief Financial Officer Other Acquisition +15,794 --
2026-08-14 Gerald Herman Chief Financial Officer Other Derivative Acquisition +12,803 $63.47
2026-08-14 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Acquisition +3,303 --
2026-08-14 Burkhard Prause President and CEO of Bruker Energy & Supercon Technologies, Inc. Other Derivative Acquisition +2,678 $57.70
2026-08-14 Juergen Srega President of Bruker CALID Group & Bruker Daltonics Division Other Acquisition +16,898 --
2026-08-14 Juergen Srega President of Bruker CALID Group & Bruker Daltonics Division Other Derivative Acquisition +13,698 $57.70
2026-08-14 Thomas Bures Chief Accounting Officer Other Acquisition +4,035 --
2026-08-14 Wolfgang Pusch -- Other Acquisition +3,120 --
2026-08-14 Wolfgang Pusch -- Other Derivative Acquisition +2,529 $57.70
2026-08-13 Mark Munch Corporate Executive VP and President of Bruker Nano Group & Corporate Derivative Exercise and Sale -2,000 $22.19–57.60
2026-08-10 Frank Laukien Chairperson & CEO Sale to Issuer -4,838 $57.02

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:23 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Bruker 公司 讨论区 0 条评论

发表评论